Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

(2019) Franciele H. Knebel et al.   Frontiers in Oncology

Possible Role and Therapeutic Target of PDGF-D Signalling in Colorectal Cancer

(2019) Renate Slind Olsen et al.   CANCER INVESTIGATION

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

(2019) J Hamfjord et al.   ANNALS OF ONCOLOGY

Analytical and clinical validation of a novel amplicon-based NGS assay for evaluation of circulating tumor DNA in metastatic colorectal cancer patients.

(2019) Beili Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule

(2019) Huawei Cai et al.   MOLECULAR PHARMACEUTICS

RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer

(2019) Chong Lai et al.   PATHOLOGY RESEARCH AND PRACTICE

Detection of mutations in circulating cell‐free DNA in relation to disease stage in colorectal cancer

(2019) Sandra Liebs et al.   Cancer Medicine

Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA

(2019) Kaoru Onidani et al.   CANCER SCIENCE

Mechanisms of Innate and Acquired Resistance to Anti-EGFR therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies

(2019) Christine M. Parseghian et al.   CLINICAL CANCER RESEARCH

Circulating biomarkers for early detection and clinical management of colorectal cancer

(2019) María Marcuello et al.   MOLECULAR ASPECTS OF MEDICINE

Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab

(2019) R. Liu et al.   Clinical & Translational Oncology

Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer

(2019) Iben Lyskjær et al.   Scientific Reports

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients

(2018) Zhu Mei et al.   BMC CANCER

The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues

(2018) Nong Yang et al.   BMC CANCER

Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients

(2018) Nele Boeckx et al.   Clinical Colorectal Cancer

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping

(2018) George Papaxoinis et al.   MEDICAL ONCOLOGY

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer

(2018) Ruilian Xu et al.   Oncology Letters

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer

(2018) Hiroki Osumi et al.   Cancer Medicine

Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients

(2018) Hangyu Zhang et al.   Translational Oncology

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

(2017) Al B. Benson et al.   Journal of the National Comprehensive Cancer Network

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

(2016) Rodrigo A. Toledo et al.   Oncotarget

Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

(2015) R. Sanz-Pamplona et al.   CLINICAL CANCER RESEARCH